A 72-year-old man presented to the emergency department with shortness of breath. He had a history of left ventricular failure, hypertension, treated esophageal carcinoma and recurrent deep vein ...

Iodinated contrast media exposure is associated with development of hyperthyroidism as well as overt hypothyroidism, according to results from a study published online January 23, 2012, ahead of print ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. 53% of patients with an iodinated contrast allergy and ...

Long-term thyroid dysfunction, including hypothyroidism and hyperthyroidism, was rare but significant among recipients of iodinated contrast media. Iodinated contrast media administration carries a ...

Please provide your email address to receive an email when new articles are posted on . Eleven patients reported 22 reactions during intradermal testing. Nine of 11 patients displayed cross-reactivity ...

People with a history of allergic-like reactions to iodinated contrast media, which is used in a variety of X-ray-based procedures, such as CT and angiography, are susceptible to similar reactions ...

The global iodinated contrast media market is set to witness a growth rate of ~6% in the next 5 years. Increasing prevalence of chronic diseases; advancements in imaging technology; growing demand for ...

Enables GE Healthcare to secure increasing supply of iodine, a key ingredient for contrast media products used in X-Ray and Computed Tomography (CT) imaging procedures Supports GE Healthcare’s broader ...

CALGARY, ALBERTA - August 25, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC: VYYRF) ("Voyageur" or the "Corporation") is pleased to announce the launch of its U.S.-based iodine ...

CALGARY, Alberta, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSX.V:VM, USA:VYYRF) (the “Company” or “Voyageur”) is pleased to announce the fully-integrated iodine business ...